Intercept Pharmaceuticals reported $92.17M in Gross Profit on Sales for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Acadia Pharmaceuticals ACAD:US $ 124.93M 14.92M
Alexion Pharmaceuticals ALXN:US $ 1511.1M 71.5M
Alnylam Pharmaceuticals ALNY:US $ 154.97M 35.33M
Amarin AMRN:US $ 111.83M 10.51M
Amgen AMGN:US $ 5097M 208M
AstraZeneca AZN:LN 6.04B 15M
Biogen BIIB:US $ 2267.1M 48.2M
Bluebird Bio BLUE:US $ 2.97M 10.8M
Bristol Myers Squibb BMY:US $ 9333M 81M
Eli Lilly And LLY:US $ 5342M 555.1M
Esperion Therapeutics ESPR:US $ 8.85M 30.01M
Gilead Sciences GILD:US $ 6198M 1371M
GlaxoSmithKline GSK:LN 6.26B 682M
Intercept Pharmaceuticals ICPT:US $ 92.17M 3.79M
IONIS PHARMACEUT IONS:US $ 130M 7.21M
Moderna Inc MRNA:US 4.25B 643M
Neurocrine Biosciences NBIX:US $ 291.8M 6M
Novartis NOVN:VX 9.52B 21M
Ptc Therapeutics PTCT:US $ 132.2M 22.89M
Regeneron Pharmaceuticals REGN:US $ 2999.6M 1445.2M
Sarepta Therapeutics SRPT:US $ 165.96M 21.39M
Vertex Pharmaceuticals VRTX:US $ 1747.65M 182.25M
YTE INCY:US $ 778.52M 105.44M